Medley, Inc. (JP:4480) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Medley, Inc. has decided to transfer all shares of its subsidiary, Medipass Co., Ltd., to MEDiPASS HOLDINGS Co., Ltd., led by Medipass’s CEO, Hiroshi Oda. This move comes as Medipass seeks to pursue independent growth strategies, positioning its business outside Medley’s core operations. Medipass had been acquired in 2021 for its online training system, which was integrated into Medley, Inc.’s JobMedley Academy, achieving significant sales growth.
For further insights into JP:4480 stock, check out TipRanks’ Stock Analysis page.